Nigeria’s Pharmaceutical Security: Why Local Manufacturing Falls Short of Drug Demand
Drug security in Nigeria.. Why does local manufacturing not meet the demand for medicines?
Nigeria faces increasing challenges related to the drug security issue in light of the continued heavy reliance on importing medicines, despite the fact that it owns more than 120 local pharmaceutical companies and factories. It is estimated that Nigeria imports at least 70% of its pharmaceutical needs, which reflects the limited capacity of local manufacturing to meet the growing demand within one of the most populous African countries.
Local manufacturing in Nigeria is mainly focused on less technically complex medicines, while more advanced and high-value medicines continue to depend on imports from abroad. Researchers and specialists also believe that this phenomenon is also linked to the economic structure and regulatory policies that have made…Importing is more profitable than investing in developing the localpharmaceutical industry
Studies indicate that many pharmaceutical companies in Nigeria combine local manufacturing with the import of finished medicines at the same time, which creates economic interests linked to continued dependence on imports, and limits the incentives necessary to expand local manufacturing of more complex medicines.
Drug security and dependence on drug imports
The high dependence on imported medicines reflects the magnitude of the challenges associated with the drug security file in Nigeria, especially with increasing pressures on global supply chains and fluctuations in international markets. The Nigerian market relies heavily on the import of finished medicines, including some medicines that are already manufactured locally, and many companies resort to combining local production withImporting under different brands.
The data also shows that dozens of companies import vital medicines despite the presence of local production. For example, only 21 local companies produce the antibiotic (Ciprofloxacin) while 93 registered companies import it. This is the same with the famous malaria treatment (Artemether-Lumefantrine), which is produced by less than 30 companies locally while more than 200 pharmaceutical companies import it, which reflects the continued attractiveness of importing compared to local manufacturing from a commercial perspective.
This heavy dependence on abroad increases the fragility of the pharmaceutical system in the face of economic crises and the disruption of global supply chains, especially with the rise in shipping and raw materials costs during recent periods. In light of these challenges, the importance of developing local pharmaceutical manufacturing is becoming increasingly important as one of the main paths to enhancing drug security and reducing dependenceOn imports in the long term.
Local manufacturing and challenges of the pharmaceutical industry
Local pharmaceutical companies in Nigeria face multiple challenges that limit their ability to expand production and enhance pharmaceutical security, especially for more technically complex medicines. These challenges include weak industrial infrastructure, high operating and energy costs, in addition to limited technological capabilities and difficulty accessing the raw materials needed for manufacturing.
Developing an advanced pharmaceutical industry also requires large investments and long and expensive learning processes, which prompts many companies to rely on importing as it is less risky and more profitable in the short term. Experts believe that weak government support and industrial incentives make it difficult for local companies to invest in…Modernizing production lines or expanding the manufacturing of advanced medicines.
Government policies and drug security
The pharmaceutical security file in Nigeria is directly linked to the effectiveness of government policies regulating the pharmaceutical sector and local industry. Since 2005, the Nigerian government has imposed restrictions on the import of 17 types of simple and less complex medicines (such as paracetamol and aspirin) with the aim of supporting local manufacturing, but these policies did not later expand to include more complex medicines.
Studies also indicate that conflicts of interest within the pharmaceutical sector represent one of the factors influencing the course of reforms, especially with some companies benefiting from continued imports alongside local manufacturing.
This situation weakens collective movements within the industrial sector to demand more supportive policies.For local manufacturing, which limits the chances of building a more sustainable and competitive pharmaceutical industry.
Pharmaceutical security, health and economic sustainability
Enhancing drug security represents an essential part of achieving health and economic sustainability within developing countries, especially with the increasing importance of stable and safe availability of medicines, which supports achieving the third goal of the Sustainable Development Goals (SDGs) on good health and well-being, and contributes to building health systems more capable of responding to crises and emergencies.
In addition to the contribution of local manufacturing in reducing dependence on imports and reducing pressures associated with fluctuations in global markets, in addition to supporting job opportunities and enhancing local industrial investments,
This is also linked to improving the ability of health systems to copeCrises and emergencies, especially in light of the challenges associated with epidemics and the disruption of international supply chains. This trend highlights the importance of building more sustainable pharmaceutical industries that rely on technology transfer, developing local manufacturing capabilities, and promoting innovation within the health sector.
Drug security and the future of local manufacturing in Africa
The Nigerian experience reflects the magnitude of the challenges facing many African countries with regard to enhancing pharmaceutical security and reducing dependence on importing medicines. Current developments indicate that developing local pharmaceutical manufacturing requires more stable and effective policies, including providing industrial incentives and supporting investment in technology, infrastructure and supply chains.
In turn,The Earth Guards Foundation confirms that enhancing drug security in…Africa, especially in Nigeria, requires building a more sustainable industrial and health system with the ability to develop medicines locally and reduce dependence on imports, in a way that supports the ninth goal related to industry, innovation, and infrastructure, in addition to the third goal related to good health and well-being, and contributes to enhancing health and economic stability and achieving sustainable development in the long term.
